Abstract:Many proteins that are aberrantly expressed in malignant tumors play important roles in promoting tumorigenesis, metastasis and immune escape. IFN regulatory factor 4-binding protein (IBP), which is a novel PH-DH-like protein related to SWAP-70, and functions as an upstream activator of Rho GTPases. It is widely expressed in cells of the immune system and is involved in coupling activated cell receptors to downstream signaling events that mediate cell proliferation, differentiation and polarization. Although IBP was detected in human chondrosarcoma, its function in tumor cells remains unknown. In this study, newly generated monoclonal anti-IBP antibodies were employed and they detected higher level expression of IBP in some human invasive breast carcinoma tissues and in two breast cancer cell lines that form highly invasive tumors in nude mice. In contrast, the levels of IBP mRNA and protein were low or undetectable in normal human breast tissues, benign breast lesions or low-tumorigenic breast cancer cell lines. Over-expression of wild-type IBP in an IBP-negative breast cancer cell line markedly increased its proliferation and invasiveness in vitro. Conversely, RNA interference-mediated knockdown of IBP expression in an IBP-positive breast cancer cell line significantly reduced cell growth and invasiveness. Our results indicate that IBP is expressed in more highly invasive human breast cancer cells, such as MCF-7 and MDA-MB-231, with lower expression in normal breast tissue, benign tumors and less aggressive breast cancer cells, such as SKBR3 and MDA-MB-453. Thus, expression of IBP is correlated with the degree of malignant breast tumors. Nevertheless, it should be pointed our that further study with more tumor types is required to fully elucidate the role of IBP in tumorigenesis and the potential of IBP as a marker for more highly malignant tumors.

Development of Ebpl in Tumor Proliferation and Invasion

A Novel Anxa2-interacting Protein Ebp1 Inhibits Cancer Proliferation and Invasion by Suppressing Anxa2 Protein Level

A Positive Feedback Loop Between EBP2 and C-Myc Regulates Rdna Transcription, Cell Proliferation, and Tumorigenesis.

Oncogenic function of microtubule end-binding protein 1 in breast cancer.

Oncogenic Function Of Microtubule End-Binding Protein I In Breast Cancer

Down-regulation of the ErbB3 Binding Protein 1 in Human Bladder Cancer Promotes Tumor Progression and Cell Proliferation

EB1 acts as an oncogene via activating beta-catenin/TCF pathway to promote cellular growth and inhibit apoptosis

The structure and function of multifunctional protein ErbB3 binding protein 1 (Ebp1) and its role in diseases

Ebp1 P48 Promotes Oncogenic Properties in Hepatocellular Carcinoma Through P38 MAPK/HIF1α Activation and P53 Downregulation.

EBP1 Promotes the Malignant Biological Behaviors of Kidney Renal Clear Cell Carcinoma Through Activation of P38/hif-1Α Signaling Pathway

Overexpression of Ebp1 inhibits the invasion and motility of adenoid cystic carcinoma cells in vitro

Expression and Role of the ErbB3-Binding Protein 1 in Acute Myelogenous Leukemic Cells

ERBB3 binding protein 1 promotes the progression of malignant melanoma through activation of the Wnt/ β-catenin signaling pathway

[Up-Regulation of ErbB3-binding Protein 1 Inhibits the Growth of Esophageal Carcinoma Cells].

Effects of over expression of ErbB-3 binding protein Ebp1 gene on growth and proliferation of HepG2 cells in human

Ectopically expressed IBP promotes cell proliferation in oral squamous cell carcinoma.

AEBP1 upregulation contributes to cervical cancer progression by facilitating cell proliferation, migration, and invasion

Bmi-1,a Polycomb Group Protein,Plays an Essential Role in Tumorigenesis and Metastasis

The Ectopic Expression of IFN Regulatory Factor 4-Binding Protein is Correlated with the Malignant Behavior of Human Breast Cancer Cells.

EBP50 Exerts Tumor Suppressor Activity by Promoting Cell Apoptosis and Retarding Extracellular Signal-Regulated Kinase Activity

Insulin-like growth factor binding protein-related protein 1 and cancer.